# Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure

> **NCT04468529** · PHASE3 · COMPLETED · sponsor: **Zensun Sci. & Tech. Co., Ltd.** · enrollment: 154 (actual)

## Conditions studied

- Chronic Systolic Heart Failure

## Interventions

- **DRUG:** Recombinant human Neuregulin for injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04468529
- **Lead sponsor:** Zensun Sci. & Tech. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-10
- **Primary completion:** 2022-04-12
- **Final completion:** 2024-04-07
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2024-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04468529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04468529, "Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04468529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*